COMPASS Pathways
COMPASS Pathways Logo
About COMPASS Pathways
Compass Pathways Plc is a biotechnology company focused on developing innovative mental health treatments. The company is advancing COMP360, a psilocybin therapy, through Phase III clinical trials for treatment-resistant depression and Phase II trials for post-traumatic stress disorder and anorexia nervosa. Headquartered in London, Compass Pathways serves patients in Europe and North America and is dedicated to accelerating patient access to evidence-based mental health care innovation.
Address
33 Broadwick Street,
London, W1F 0DQ
United Kingdom
Year founded
2020
Number of employees
300-400
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
